Rayner launches spiral IOL designed by AI

News
Article

The RayOne Galaxy and Galaxy Toric IOL will launch at this year's ESCRS Congress in Barcelona, Spain.

Two boxes of of Rayner IOLs Image credit: Rayner

Image credit: Rayner

On Monday, ophthalmic surgery manufacturer Rayner announced a new addition to its intraocular lens (IOL) offering, designed using a proprietary artificial intelligence (AI) engine. In a press release, Rayner, based in Worthing, UK, shared details about the RayOne Galaxy and Galaxy Toric, which will launch at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) Congress in Barcelona, Spain.1 The lens will come fully preloaded across the RayOne product line’s power range and will be immediately available in toric powers.

According to Rayner, the RayOne Galaxy has a unique spiral lens, formulated to deliver a continuous full range of vision and minimise dysphotopsia. The company developed the RayOne Galaxy in conjunction with João Marcelo Lyra, MD, PHD, who is affiliated with Universidade Estadual de Ciências da Saúde de Alagoas (UNCISAL), Maceio, Alagoas, Brazil. Additionally, the IOL was developed using an AI “trained on patient outcomes,” resulting in a non-diffractive optic with 0% light loss. The press release from Rayner noted the lens is the “world’s first spiral IOL designed with artificial intelligence.”

Clinical investigations with RayOne Galaxy began earlier in 2024 in Brazil and throughout Europe.1 Eight leading surgeons began using the RayOne Galaxy in their clinical practices, and a number of those surgeons will present initial findings at a Rayner symposium during the ESCRS Congress. Mr Allon Barsam, Consultant Ophthalmic Surgeon and Director at OCL Vision in London, United Kingdom, said the first patients received the RayOne Galaxy lens at OCL Vision in July. “Their feedback so far has been overwhelmingly positive, with patients reading without glasses and thrilled with their quality of vision,” Mr Barsam reported in the press release.

Tim Clover, CEO of Rayner, gave a statement about the AI-supported development of the lens. “We all read about the life changing potential of AI, but this is a real-world example of technology impacting the outcomes of patients,” he said. “RayOne Galaxy represents a next generation technology in intraocular lenses to enable patients to see without spectacles.”

Reference:
  1. Rayner announces launch of world’s first spiral IOL designed with AI. Press release. Rayner Group. Published 26 August, 2024.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.